AMN Healthcare: Strong Execution And Rerate Leaves Less Upside Going Forward

AMN Healthcare's Q1 was strong, but most of the upside came from labor disruption revenue rather than underlying demand. Excluding disruption revenue, quarterly sales were roughly flat year over year, and management's Q2 guidance implies a sharp decline in disruption revenue from the elevated Q1 level. The update points to softer near-term momentum despite the headline beat.

Analysis

AMN Healthcare's Q1 was strong, but most of the upside came from labor disruption revenue rather than underlying demand. Excluding disruption revenue, quarterly sales were roughly flat year over year, and management's Q2 guidance implies a sharp decline in disruption revenue from the elevated Q1 level. The update points to softer near-term momentum despite the headline beat.